Inmune Stock Forecast

Buy or Hold candidate since Jun 18, 2026 Gain 42.76%

No changes to the price of Inmune stock on the last trading day (Thursday, 16th Jul 2026). During the last trading day the stock fluctuated 5.22% from a day low at $1.99 to a day high of $2.10. The price has risen in 6 of the last 10 days and is up by 23.21% over the past 2 weeks.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $2.08 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 19.47% during the next 3 months and, with a 90% probability hold a price between $1.60 and $2.48 at the end of this 3-month period.

INMB Signals & Forecast

The Inmune stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.92 and $1.52. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 15, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point".

Support, Risk & Stop-loss for Inmune stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.94 and $1.74. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Inmune finds support just below today's level at $1.94. If this is broken, then the next support from accumulated volume will be at $1.74 and $1.68.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.104 between high and low, or 5.22%. For the last week the stock has had daily average volatility of 10.03%.

The Inmune stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $2.00 (-3.42%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 79 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (INMB) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect Inmune Bio Inc. to open at $2.05, and during the day (based on 14 day Average True Range), to move between $2.00 and $2.14, which gives a possible trading interval of +/-$0.149 (+/-7.49%) up or down from last closing price. If Inmune Bio Inc. takes out the full calculated possible swing range there will be an estimated 7.49% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $1.94, some $0.130 (6.28%) from the current price of $2.07, our system finds the risk reward attractive.

Is Inmune Bio Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Inmune stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.559 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $2.05 ( 0.87%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk